Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Gamelin Erick sold 400 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Gamelin Erick (Chief Development Officer) sold 400 Acrivon Therapeutics, Inc. shares at US$2.01 for US$804, leaving 52,592 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 400 shares
- Price
- US$2.01
- Value
- US$804
- Holding after
- 52,592 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 400 | US$2.01 | 52,592 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Gamelin Erick
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Gamelin Erick · May 20, 2026
- Form 4 · Gamelin Erick · May 18, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026